The author tried to review and summarize low-dose effects of endocrine disrupting chemicals (EDCs) through an extensive literature survey of toxicological studies with bisphenol A (BPA), taking BPA as an example for which many studies were published. Data on low-dose effects with BPA, especially on neurobehavioral effects after fetal or early postnatal exposures, suggested that there would ters to allow adequate statistical analysis and appropriate selection of dosages to obtain insight in doseresponse relationship. Secondly, precise measurement of plasma levels in both humans and rodents and construction of relevant physiologically-based pharmacokinetic models would help obtain quantitative estimates of intake and target-organ exposure relationship. Thirdly, biological backgrounds, particularly differences and similarities in endocrinological, neurological and immunological aspects among species, should be revisited. Fourthly, mechanistic deliberations on the possibilities of epigenetic mechanism and examinations of putative neurobehavioral effects or a presumptive link of miscarriage with BPA exposures are requested. Finally, general public concerns must be addressed in a thoughtful way so that a simple precautionary approach is not pursued, but uncertainties of the new toxicological aspects should be carefully explained. Further researches and internationally concerted efforts on elucidating risk of lowdose effects by integrating knowledge will contribute to setting new directions in toxicology and improving chemical risk assessments.
INTRODUCTION Early descriptions of low-dose effects by endocrine-disrupting chemicals
From inception of early warning by Rachel Carson in 1962 depicted in "Silent Spring" of the potential adverse effects of chemicals to human health and wildlife, many researches have been conducted to answer questions and resolve concerns in this direction. The term, endocrine-Wingspread conference in 1991 as a new concept in toxicology for the changes which are induced by chemicals through disturbance in regulation of endocrinological actions. One of the intriguing claims is that EDCs, like hormones, exert their effects at very low dose levels but those effects may not be observed at relatively high dose because of a homeostatic mechanism. EDCs may cover a variety of chemical classes including hormones, plant constituents, pesticides, compounds used in the plastics industry and other industrial by-products and pollutants. Bisphenol A (BPA) was named as one of the EDCs for its weak estrogenic action shown in in vitro assays, and putative low-dose effects of BPA raised much concern, for its wide use in consumer products and in dental therapy, etc.
In line with the notion of EDC, vom Saal et al. (1997) reported that fetal exposure to low doses of estradiol or diethylstilbestrol caused prostate enlargement in mice, while they had opposite effects at high doses. Furthermore, they reported that BPA, when dosed to female mice for gestation day 11-17, permanently increased preputial estrogenic activity (vom Saal et al., 1998) .
Endocrine disruptors low-dose peer review by National Toxicology Program
National Institute of Environmental Health Sciences (NIEHS) organized a workshop and conducted a scientific peer review of the reported low-dose reproductive and developmental effects at the request of the USA Environthat low-dose effects were demonstrated in laboratory animals exposed to certain endocrine active agents, although the effects were dependent on the compounds studied ings could not be replicated (NTP, 2001) . Since the traditional multigeneration reproduction study protocol has not revealed major reproductive or developmental effects in rodents at doses approaching lowest-observed-adverseeffect level (LOAEL, see below) observed by the standard testing paradigm, they indicated that the classical testing paradigm used for reproductive and developmental toxicity should be revisited to see if changes are needed regarding dose selection, animal model selection and age of the animals for the exposure to endocrine active agents.
They further reported that several studies provided credible evidence for low-dose effects of BPA, such as the increased prostate weight in male mice at six months of age after in utero to the LOAEL estimated by EPA for oral exposure to BPA in rats (US EPA, 2008) . A clear difference, however, was observed in sensitivity between strains of rats, e.g., F344 and Sprague-Dawley in occurrence of low-dose effects in comments were made that not only differences in genetic backgrounds of the strains, but also different diets with different background contamination by phytoestrogens etc. might have contributed to the differences in hormonal levels in animals resulting in the discrepancies in experimental outcomes, and that additional research should clarify uncertainties related to the low-dose effects of BPA (NTP, 2001) .
Global assessment by International Programme on Chemical Safety
In 1997, International Programme on Chemical Safety (IPCS) of the World Health Organization convened a group of international scientists to assess the state-of-thescience of EDCs and prepared a global assessment report (IPCS, 2002) . They discussed issues of mechanism of action, dose-response relationships, effects in wildlife and to humane health, exposure to selected potential EDCs, and causal criteria and weight-of-evidence framework for the effects resulting from exposure to EDCs. They considered that endocrine disruption is not a toxicological endpoint per se but a functional change that may lead to stance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organisms, or in progeny, or (sub)populations", and discriminated a potential EDC from EDC, as "an exogenous substance or mixture that possesses properties that might be expected to lead to endocrine disruption in intact organisms, or in progeny, or (sub)populations."
A framework was proposed based on the aspects of temporality, strength of the association, consistency of the observations, biological plausibility and evidence of recovery. Five areas of the further efforts and researches, namely biology underlying endocrine-mediated effects, methodology, monitoring, identification of EDCs and database development, were considered of high priority.
The IPCS group stressed the importance of understanding endocrine systems and mechanistic considerations in evaluating effects of EDCs. For example, (i) normal homeostatic mechanisms (e.g., down-regulation of receptor expression) may compensate possible effects in adulthood exposures, (ii) however, exposure during the period of programming of the endocrine system in progress (critical windows of exposure) may result in permanent ry signals, (iii) exposure to the same level of an endocrine signal at different stages in life history may produce different effects, (iv) because of cross talk between different endocrine systems, effects may occur unpredictably, (v) and therefore, considerable caution should be exerted in extrapolating in vitro measures of hormonal activity to the situation in vivo. IPCS further mentioned that tive and immune dysfunction in Baltic seals, or eggshell thinning and altered gonadal development in birds, might be related to exposure to organochlorines (polychlorinated biphenyls: PCBs, 2,2-di-(p-chlorophenyl)-1,1dichloro-ethylene: DDE) and 1,1,1-trichloro-2,2-di-(pchlorophenyl)ethane (DDT), although precise mechanisms remained unclear, and that masculinization and decline of populations of marine gastropods was more clearly related to exposure to organotin compounds such as tributyltin compounds (TBT) used in antifouling paints for boats.
Development of testing guidelines by Organisation for Economic Co-operation and Development
Organisation for Economic Co-operation and Development (OECD) developed a series of guidelines, which are relevant to testing chemicals that may have a potential to exert endocrine disrupting effects as follows: Test No. 415 for one-generation reproduction toxicity study (1983) ; No. 424 for neurotoxicity study (1997) ; No. 416 for twogeneration reproduction toxicity study (2001) ; No. 414 for prenatal developmental toxicity study (2001); and No. 426 for developmental neurotoxicity study (2007) . These guidelines constitute harmonized testing protocols and data reporting requirements to support meaningful comparisons of the data produced by various laboratories, especially where discrepancies were observed in the outcomes of tests with different experimental designs utilized in neuropathology or in behavioral studies.
TOXICOLOGICAL REVIEW OF LOW-DOSE EFFECTS OF BISPHENOL A
Literature survey of toxicological studies on bisphenol A Bisphenol A (CAS No. 80-05-7) is a component of epoxy resins used to make hard plastic polycarbonate bottles and containers. Its production volume in Japan was 445 thousand tons in 2002 with 162 and 41 thousand tons for export and import, respectively (MOE, 2004) .
There have been many studies on BPA focusing mostly related to presumed its endocrine disrupting potential. The total number of literature searched with the CAS No. 80-05-7 in PubMed till June 23, 2008 was 1,137, of which 1,029 were published in the period after 2000, indicating increasing concerns and active researches of this compound in recent years. As a part of the research project supported by the Ministry of Health, Labour and Welfare (MHLW) Japan, the author surveyed literature on BPA, especially with special interest on the potential low-dose effects of the compound, and developed a series of reports with the data books (in Japanese) on low-dose effects of BPA (Sekizawa, 2005 (Sekizawa, -2009 . Literature was searched using the CAS No. 80-05-7 in PubMed. Toxicological studies in animals and epidemiological studies for humans were searched, excluding those of analytical methods, effects to organisms in the environment, elution from dental resin formulations, etc. Human exposure data, and toxicokinetics and metabolism studies with humans and animals were searched, too. Also, major reviews by international organizations and national scien--lected and the data were examined carefully with respect to study design, experimental conditions, data presentation and statistical analysis.
Selection of toxicological studies
No human studies were available which adequately related the observed effects with BPA exposures. Studies of rats and mice, with which most of studies were conducted and plenty of background information was available, were examined, but studies with other experimental animals were excluded. Table 1 summarizes the low-dose effects data in the order of the LOAELs from low to high es will be found below). Although there are studies which showed no effects at low-dose exposure levels from various reasons, they are not named specifically in this review. For example, when two generations of rats were BPA prior to and during mating and throughout the gestation and lactation period, none of the observed effects covering wide ranges of developmental or reproductive endpoints were related to BPA treatment despite careful experimental design and data treatment (Ema et al., 2001) . For details and discussion of each study, readers are recommended to refer to either original literature or reviews of governmental and international bodies cited in this review, and later sections, respectively. Since human exposure to BPA is known to be overwhelmingly through the oral route (NTP, 2008) , those studies which used gavage or oral exposure via food or drinking water were considered relevant in evaluating human health implications; and only data of gavage or oral exposure studies were examined for low-dose effects and those from other routes of exposure were excluded. Endpoints considered here are structural or functional disorders which have implications to health, and biochemical changes in hormone levels or effects to gene expressions which are hazards observed at low doses. For statistical analysis, the number of animals per group etc. was checked; however the author relied in general on the recent judgment made by the expert group of Center for the Evaluation of Risks to Human Health Reproduction (CERHR) in this aspect (CERHR, 2007) . The adequacy of the studies in examining low-dose effects determined by the group of CERHR experts is also indicated in the table. level (NOAEL) which was derived from a comprehensive three-generation study in rats in which the lowest (EFSA, 2006) . A recent two-generation reproductive toxicity study in mice conducted following the OECD test guideline 416 (OECD, 2001a) and in compliance with Good Laboratory Practice (GLP) gave the same LOAEL a 500-fold uncertainty factor, comprised of 10 for interspecies differences, 10 for inter-individual differences and 5 for uncertainties in the database on reproductive and developmental toxicity. The last factor of 5 is considered no longer required because the database has been (EFSA, 2006) . US EPA set oral reference dose (RfD) or mean body weight in early weeks of exposure in a rat chronic toxicity study conducted by NTP (1982), applying an uncertainty factor of 1,000 (10 for inter-species differences, 10 for inter-individual differences and another 10 for uncertainty in the effects of duration on toxicity), and this RfD has been maintained (US EPA, 2008).
the evaluations by different agencies, and thus this dose level is used as a tentative cutoff dose for the low-dose effects in this review.
Outcome of toxicological study review
At least 20 studies (11 in rats and 9 in mice) which were regarded reporting low-dose effects are found (Table  1 ). Of those, 17 studies reported developmental effects and 3 studies reported reproductive effects. It is striking that 18 reports of low-dose effects out of 20, were observations made on pups from dams exposed during pregthere might be critical windows of exposure for low-dose effects in developmental or reproductive effects. Out of 17 studies on developmental effects, 9 studies reported behavioral effects in pups that resulted from maternal sures. Three studies noted impairment in sexual differentiations either morphologically in organs or in behavior, or both. Regrettably, 10 low-dose studies were conducted using only a single dose level and sometimes with a to assess dose-response relationship with the effects, and were regarded as adequate and of high utility, of limited utility, and inadequate for the evaluation of low-dose effects, respectively (see Note column in Table 1 ). It expressions among species or strains tested. Fig. 1 shows the distribution of dose levels with regard to effects in the order of effect levels from low to high, with observed effects and animal species in the horizontal axis and the dose level in the ordinate axis. In 9 out of 20 studies, effects were observed at doses lower than 10 sies with the low-dose effects, it can be said at least that many evidences suggesting low-dose effects, especially of developmental effects after perinatal exposures, have been compiling recently.
EXPOSURE ESTIMATION

Exposure estimate by international or national organizations
The primary source of human exposure to BPA is considered via diet through contamination of the plastic monomer eluted from various sources (NTP, 2008) . Human exposure has been estimated by direct measurement of human tissue samples, such as serum, breast milk, urine, or from dietary studies where concentrations in food and beverages were measured and an aggregate exposure was calculated by multiplying food and drinking water consumption data. Exposure estimates by several organizations are summarized in Table 2 .
Exposures for infants, children and adults were esti-tively as an aggregate of exposures from various sources through the studies performed in the USA, Europe and Japan (CERHR, 2007) . When the intake was back calculated from urine data based on toxicokinetic studies (see below) on BPA, the average intake values for females and males were 0.044 and 0.057, respectively (NTP, 2008) .
Scientific panel on "food additives, flavourings, processing aids and materials in contact with food" of the EFSA assumed conservative scenarios in estimating the aggregate exposure from various sources, and thus, relatively high values are presented in the table (EFSA, 2006) . They estimated that the potential exposure of breastfed -en in Japan (Sun et al., 2004) . The dietary exposure of 3-month infants weighing on average 6.1 kg and consumfrom canned powdered infant formulae based on German DONALD study (Kersting, 1998) , is summed up to months (average weight 7.8 kg) was estimated to be 8.3 from polycarbonate (PC) bottles, and that in 1.5-year-food storage container), while that in adults consuming 3 tableware and food storage container).
potential human exposure, applying Monte Carlo simulation to the urine data in two Japanese studies with 36 young male adults or 22 adults (11 each of males and females). The exposures were estimated to be 0.028-0.049 adults based on the assumption that the amount of BPA daily excretion in urine was considered equivalent to that of daily uptake. This assumption was based on the data that 97-118% of orally dosed deuterium-labeled BPA was recovered in urine as either free BPA or glucuronide. BPA glucuronide was cleared from human blood and excreted in urine with terminal half life of less than 6 hr (Völkel et al., 2002) .
Other exposure estimates
Concentrations of free-form (i.e., not conjugated) BPA were measured in the serum samples, placental tissues and umbilical cord from 37 pregnant mothers (32-41 weeks of mass spectrometry (MS) after specific derivatization (Schönfelder et al., 2002b) . Median concentrations and fetal plasma, maternal plasma and placental tissue, respectively. BPA concentrations in fetal plasma were higher in males than in females. The data showed that placenta did not work as a barrier to BPA contamination from mothers, and male fetuses may be exposed to higher concentrations than females. Vandenberg et al. (2007) reviewed human serum concentration data of BPA measured by methods and discussed values of free BPA in serum were much higher than expected from the toxicokinetic study worst case estimates for daily indirect human exposures to BPA), were dosed (Völkel et al., 2002) . When d 16 -BPA was orally administered to 9 human subjects (3 female and 6 male ages from 24 to 57), elimination was complete within 24-hr with a terminal half-life in blood of 5.3 hr. Peak blood concentrations of BPA-glucuronide meas-MS reached a concentration of approximately 150-200 et al., 2002) . In a case-control study comparing women with recurrent spontaneous abortions (n = 45) to healthy nulligravid women (n = 32) from the same city in Japan, mean val-- (Sugiura-Ogasawara et al., 2005) . Vandenberg et al. (2007) estimated blood levels of free BPA of rats and mice after a single oral administration at studies of higher dose exposures in which measurement of free BPA was reported. Their estimation indicated that respectively, which were lower than the BPA blood levels measured in humans above. This is apparently contradicting to the report of more rapid metabolism and clearance of BPA in humans than in rodents (Teegurden et al., 2005) ; and the estimated human exposure could become
IMPLICATIONS TO HUMAN HEALTH
Recent reviews by governmental and international bodies, etc.
Government of Canada initiated on April 19, 2008, a 60-day public comment period on whether to ban the importation, sale and advertisement of baby bottles which issued a report on reproductive and developmental toxicity of BPA based on the review by the CERHR expert panel (CERHR, 2007) . They summarized that no data on human developmental exposure to BPA are available, but rodent studies suggest that BPA causes neural and behavioral alterations related to disruptions in normal sex dif-es male or female reproductive toxicity in humans. However there is sufficient evidence in rats and mice that BPA causes female and male reproductive toxicity with subchronic or chronic exposures at relatively higher dosbrief on BPA based on the report of CERHR (2007) for a of the NTP-CERHR Monograph on BPA in late summer 2008. Based on human observations and laboratory animal study, they concluded that there is some concern for neural and behavioral effects in fetuses, infants, and children at current human exposures. The NTP (2008) also has some concern for BPA exposure in these populations based on effects in the prostate gland, mammary gland and an earlier age for puberty in females ( (See NOTE)
What are the critical data gaps?
Most low-dose studies were conducted with a single response relationship. Since the testing guideline for developmental neurotoxicity was developed by OECD credibility of the data in accordance with the internationally harmonized protocol. Though there are criticisms on the study design, experimental conditions and statistical analysis of the existing studies, it may be useful to carefully examine the possibility of effects in neonates or risk of developmental effects which may be detected in the later stages of life, as NTP (2008) noted in their draft.
trations of BPA as well as the serum concentrations in rodents when effects are observed at low doses, because the human serum data are apparently contradicting the estimated values from human intake data. The serum levels in humans have been assumed to be much lower than in rodents since it has been claimed that the effects would amount from food, because of more efficient clearance of BPA in humans than in rodents. More precise understanding is required of pharmacokinetics and metabolism of BPA in humans and rodents as well as the key factors, if any, which may differentiate toxic effects between humans and rodents.
Since it was claimed that BPA can be a potent meiotic aneugen to elicit detectable meiotic effects in the female mouse after a short-term, low-dose exposure during the et al., 2003) , and aneuploidy is the leading cause of spontaneous abortion in humans (accounting for 30-60% of spontaneous abortions), the presumptive link between BPA exposure and miscarriage as mentioned above, must be examined by a well-designed study.
Importance of mechanistic consideration
Up to the present day, numerous data have been comor reproduction through exposure during the critical window of perinatal period which may persist to later periods tions, however, must be examined and considered by not only assuring reproducibility of data, but also integrating evidences from mechanistic studies, e.g., studies in vitro or on molecular levels. In this regard, although not much mention was made to the studies of signal transduction and gene expression, they might offer some clues to shed lights to the background mechanism of effects through BPA exposure during the critical window of perinatal period.
For example, tributyltin (TBT) compounds, a notorious EDC, was known to cause imposex (masculinization of female gastropods) with a no-observed-effect level dependent immune responses in rats with the LOAEL er, not easy to understand whether there was some link between these effects until the discovery that TBT was a et al., 2001) . There is good evidence that the membrane-limited actions of hormones, particularly estrogens, involve the rapid activation of kinases and the release of calcium and that these are linked to physiologically relevant scenarios in the brain (Vasudevan and Pfaff, 2008) . Membrane actions of estrogens activate rapid signaling cascades, and also potentiate nuclear transcription in both the central nervous system and in non-neuronal cell lines. Vasudevan and Pfaff (2008) presented a theoretical scenario to under- 
NTP conclusions on effects of Bisphenol A (BPA)
In concurrence with the CERHR Panel Report, there is some concern for neural and behavioral effects in fetuses, infants and children at current human exposures. NTP has NTP has negligible concern that exposure of pregnant women to BPA will result in fetal or neonatal mortality, birth defects or reduced birth weight and growth in their offspring.
In concurrence with the CERHR Panel Report, there is negligible concern that exposure to BPA causes reproductive effects in non-occupationally exposed adults and minimal concern for workers exposed to higher levels in occupational settings NOTE in the main text on the recommendation for changes
Weight of evidence approach for respective effects from human observations and animal studies 1 .
There is some evidence that BPA causes adverse reproductive effects in laboratory animals 2 . 3 . #1-5 #1,2,6 and delayed #2,6-8 #5 #9 and cellular effects on the testis of male rats (235 #10 . #11-17 #18 and mammary glands (25 #19,20 #21 #15,22 . stand this phenomenon that these signaling cascades may occur in parallel or in series but subsequently, converge estrogenic activity of BPA was claimed to be fairly low as compared to estradiol (E 2 ), recently, BPA was found to be and could cause rapid estrogen-mediated signal-regulated kinase signaling in developing rat cerebellar neurons as a potent nongenomic agonist at 10 -12 M concentration as comparable to E 2 (Zsarnivsky et al., 2005) . Ohtake et al. (2003) found that estrogenic action of arylhydrocarbon receptor (AhR) agonists might be exertarylhydrocarbon receptor nuclear translocator (Arnt) and unliganded ER and by the formation of functional units bound to estrogen responsible element (ERE) to activate transcription in uterine gene induction, but AhR agonists exhibit anti-estrogenic activities in the presence of high doses of E 2 in animals and cultured cells by repressing liganded ER. Thus, not only the presence or absence of estrogens, but also the presence of AhR ligands at certain levels might regulate exquisitely the expression of estrogen dependent activity in the target cells. Embryonic er orally to gravid mice in gestation days 6 to 17) markedly increased expressions of mRNA of AhR, retinoic la, testes or ovaries at gestation days 14 or 18 (Nishizawa et al., 2005) .
Cross talk between receptors and possibility of epigenetic mechanism
Understanding the potential of epigenetic changes may explain the mechanism of developmental effects of BPA or other EDCs (vom Saal, 2007) . Developmental exposure to BPA increases the susceptibility to prostate carcinogenesis and epigenetically regulates phosphodeiestrase type 4 variant 4 . In this regard, it is interesting that the role of premature leptin surge in obesity resulting from intrauterine undernutrition was reported (Yura et al., 2005) . Offspring with fetal undernutrition, when fed a high-fat diet develop pronounced weight gain and adiposity, and therefore, a mother who admires slim body and eats less may affect her child obesity. Penetrance in genetic inheritance may also somehow relate to the different effects between studies. Not only for BPA, but for other protocols to elucidate the issue of critical period of exposure, which may lead to developing new aspects in toxicology.
Species differences in endocrinology and pharmacokinetics
Precise understanding of species differences not only in pharmacokinetics and metabolism, but also basics in endocrinological differences between humans and rodents is required in extrapolating animal data to humans. Witorsch (2002) pointed that there are major differences between humans and rodents in the role of the corpus luteum during pregnancy, hormonal control of the corpus luteum of pregnancy, the source and pathways of sex steroid production throughout gestation, and the specific types of estrogens secreted and the levels within the fetus attained throughout gestation. He noted also that concentrations of E 2 in late stage of gestation in mothers ble to xenoestrogens at lower doses compared to humans.
Further research studies and internationally concerted efforts will be necessary to assess risks associated with exposure to BPA. These efforts will further contribute to the development of new aspects in toxicology and ensuring safe use of chemicals in general.
DISCUSSION
Aim of this review
This review is not meant to be comprehensive and exhaustive, or to present a new estimation of risks with BPA exposure, particularly because the risk assessment will require integration of all available knowledge and thoughtful discussions by experts in various fields, as well as involvement of other stakeholders, eg., suscepti-sary. Rather, the author, having worked as a member of the IPCS chemical risk assessment group for more than 20 years, would try to review and summarize the matter of EDCs taking BPA as a good example for which many studies have been conducted and published, to consider ment.
While there has been much dispute over low-dose effects of BPA partly because of its wide use in polymer production, by reviewing the data on low-dose effects with this compound, especially those on neurobehavioral effects following fetal or early postnatal exposures, it is suggested that there are new aspects to be considered carefully, and that it is imperative to pursue further investigations.
Future tasks and challenges
Specific mention for future tasks and challenges is made as follows. Firstly, animal toxicity tests should be number of test animals with careful handling of litters to avoid litter effects to allow adequate statistical analysis, and appropriate selection of multiple dose levels to obtain insight in dose-response relationship. Secondly, precise be estimated to allow extrapolation of effects observed in rodents to humans, and in this connection, construction of relevant physiologically based pharmacokinetic models, would help obtain quantitative estimates of intake and target-organ exposure relationship. Thirdly, biological backgrounds, particularly differences and similarities in endocrinological, neurological, and immunological aspects among species or strains, should be revisited to explain what were observed in certain species or strains. Fourthly, mechanistic deliberations, e.g., on the possibil-neurobehavioral effects or a presumptive link between miscarriage and BPA exposure through well-designed epidemiological studies are requested. Finally, general public concerns, particularly of women who are going to bear babies, should be addressed in a thoughtful way so that a simple precautionary approach is not pursued, but uncertainties in the new toxicological aspects should be carefully explained. Further research studies and internationally concerted efforts will be necessary to assess risks from low-dose effects through integrating available setting new directions in toxicology and improving risk assessments of chemicals.
NOTE
Following information pertinent to this review was obtained after submission of the draft.
"Action on the draft brief on Bisphenol A" on June 11, 2008 recommending changes in the level of concern in the Draft NTP Brief on Bisphenol A from "some" to "minimal" for effects in the mammary gland and an earlier age for puberty in females taking into consideration 
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